Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial
View abstract on PubMed
Summary
This summary is machine-generated.Intensive follow-up for colorectal cancer patients using frequent computed tomography scans and carcinoembryonic antigen tests did not significantly reduce mortality or recurrence rates compared to less frequent testing.
Area Of Science
- Oncology
- Clinical Trials
- Cancer Screening
Background
- Intensive follow-up is standard after colorectal cancer surgery, but its survival benefit is not well-established.
- Optimal follow-up schedules for stage II or III colorectal cancer require further investigation.
Purpose Of The Study
- To compare the effectiveness of high-frequency versus low-frequency follow-up schedules.
- To evaluate the impact on overall mortality, colorectal cancer-specific mortality, and recurrence rates.
Main Methods
- An unblinded randomized trial involved 2509 patients with stage II or III colorectal cancer.
- Patients received either high-frequency (6, 12, 18, 24, 36 months) or low-frequency (12, 36 months) follow-up with CT scans and CEA tests.
- Follow-up duration was 5 years.
Main Results
- No significant difference in 5-year overall mortality (13.0% vs 14.1%) or cancer-specific mortality (10.6% vs 11.4%) between groups.
- Colorectal cancer-specific recurrence rates were also similar (21.6% vs 19.4%).
Conclusions
- More frequent follow-up testing with computed tomography and carcinoembryonic antigen does not significantly improve survival outcomes for stage II or III colorectal cancer patients.
- Current follow-up strategies may warrant re-evaluation based on these findings.